💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for ANI Pharmaceuticals, Inc. (ANIP)
« Back to company indexANIP Chatter Timeline
Stock Ticker for ANIP
Most Active Tweeters for ANIP
| User | Tweets |
|---|---|
| @A1Syad | 6 |
| @newsfilterio | 3 |
| @FlashAlert_me | 2 |
| @ChartMill | 2 |
| @Tickeron | 2 |
Recent Tweets for ANIP
 |
@A1Syad $ANIP Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/T9qmRRwUcJ December 3rd 2021, 8:12pm |
 |
@ericpisauro @lblegend33 Check out $anip recent FDA approval for cortrophin, only approved competition to acthar gel, big opportunity imo December 2nd 2021, 4:12pm |
|
@A1Syad $ANIP Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/RxQBzJdCgC December 1st 2021, 9:12pm |
 |
@poodirg The CEO remuneration of $ANIP is 6 million in the fiscal year of 2019. Few companies in the industry pay such a lev… https://t.co/Vut3taGJDT December 1st 2021, 1:12am |
|
@A1Syad $ANIP Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/QLfTm3Eztq November 30th 2021, 8:11pm |
|
@A1Syad $ANIP Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/W3pyikiJKX November 26th 2021, 11:11pm |
 |
@1speculator $ANIP, rolled out to Jan 21, same strike at 40, for 1.50 credit, total premium received is now 3.18, ref=40.50 https://t.co/Zjr8i4sXpA November 26th 2021, 5:11pm |
 |
@EdgarInsider FORM 8-K [Press/News Current Report] recently SEC filed. $ANIP ANI PHARMACEUTICALS INC https://t.co/RymoqqKc8k November 26th 2021, 11:11am |
|
@A1Syad $ANIP Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/Y3f5tR6luC November 25th 2021, 7:11pm |
 |
@ChartMill Based on estimates for the next 5 years, $ANIP will show a very strong growth in EPS: 25.14% on average per year.… https://t.co/JsKnB9jKe8 November 25th 2021, 2:11am |
 |
@mediasentiment $ANIP new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 659 November 24th 2021, 6:11pm |
 |
@Tickeron $ANIP enters a Downtrend because Momentum Indicator dropped below the 0 level on November 15, 2021. View odds for t… https://t.co/aiBWsMnzQX November 24th 2021, 8:11am |
 |
@newsfilterio Form 3 (initial statement of beneficial ownership of securities) filed with the SEC $ANIP https://t.co/l6XU9FEe5h November 24th 2021, 6:11am |
|
@newsfilterio Form 3 (initial statement of beneficial ownership of securities) filed with the SEC $ANIP https://t.co/ruyzBruB1l November 24th 2021, 6:11am |
|
@Tickeron $ANIP enters a Downtrend as Momentum Indicator dropped below the 0 level on November 15, 2021. View odds for this a… https://t.co/7UwKoUeF3Z November 23rd 2021, 10:11pm |
|
@A1Syad $ANIP Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/eESlnvHxXv November 23rd 2021, 8:11pm |
 |
@equity_newswire $ANIP ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Sc… https://t.co/7tDZukEEFL November 22nd 2021, 2:11pm |
 |
@MarcJacksonLA https://t.co/svyTiRVCd1 | $ANIP ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021 November 22nd 2021, 2:11pm |
 |
@SmallCapsDaily $ANIP ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Sc… https://t.co/gSP9FyUddt November 22nd 2021, 2:11pm |
|
@MarcJacksonLA $ANIP ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Sc… https://t.co/7N66FwVpX1 November 22nd 2021, 2:11pm |
|
@equity_newswire $ANIP ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021 https://t.co/Jz36wfoA0f November 22nd 2021, 1:11pm |
 |
@gcassidy718 $ANIP ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Sc… https://t.co/OAcLzKfmOm November 22nd 2021, 1:11pm |
|
@gcassidy718 $ANIP ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021 https://t.co/us6DeiYeyh November 22nd 2021, 1:11pm |
 |
@DmitryKovalchuk $ANIP here we go! ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabi… https://t.co/mAPJIDmQDe November 22nd 2021, 12:11pm |
 |
@otcdynamics $ANIP ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021 https://t.co/WV3q7fA2AY November 22nd 2021, 12:11pm |
|
@otcdynamics $ANIP ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Sc… https://t.co/DKaT644aEW November 22nd 2021, 12:11pm |
 |
@FlashAlert_me $ANIP [15s. delayed]: Issued Press Release on November 22, 06:50:00: ANI Pharmaceuticals Completes Acquisition of N… https://t.co/NbKrdsIbwM November 22nd 2021, 11:11am |
 |
@StockNewsBot2 $ANIP ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Sc… https://t.co/GPpybH0Tmw November 22nd 2021, 11:11am |
 |
@quantisnow $ANIP ? ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and… https://t.co/lFqD4KSiKE November 22nd 2021, 11:11am |
 |
@stock_titan $ANIP ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Sc… https://t.co/Iq8tYrX1zd November 22nd 2021, 11:11am |
|
@FlashAlert_me $ANIP [15s. delayed]: Issued Press Release on November 22, 06:40:00: ANI Pharmaceuticals to Present at the Piper Sa… https://t.co/ZCrkbuASqz November 22nd 2021, 11:11am |
|
@newsfilterio ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021 $ANIP https://t.co/xVKwiOQOV9 November 22nd 2021, 11:11am |
|
@StockNewsBot2 $ANIP ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021 https://t.co/Z1PgoCeNkP November 22nd 2021, 11:11am |
|
@stock_titan $ANIP ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021 https://t.co/W3cFuoxsyU November 22nd 2021, 11:11am |
|
@DmitryKovalchuk As per PR, $ANIP has expected to complete the Novitium Pharmaceuticals merger by 18.11.2021. I had expected them t… https://t.co/wbVJsKn9c4 November 22nd 2021, 11:11am |
|
@ChartMill $ANIP was analyzed by 8 analysts. The buy consensus is at 80%. So analysts seem to be mildly confident about $ANIP.… https://t.co/GKmsjKQhJF November 21st 2021, 11:11am |
|
@A1Syad $ANIP Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/11EGjL6AjT November 19th 2021, 11:11pm |
|
@MarcJacksonLA $ANIP ANI Pharmaceuticals Alleges Poaching, Confidentiality Breach https://t.co/NXznnUGrVR November 19th 2021, 4:11am |
|
@A1Syad $ANIP Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/0aQJS1Q2Bn November 18th 2021, 10:11pm |
 |
@andydicesorkin @given2tweet You still in $ANIP? November 18th 2021, 3:11pm |
|
@Tickeron $ANIP's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/A3kSWhoWld November 18th 2021, 12:11pm |
|
@eoobook The CEO’s compensation (6 million) of $ANIP is 90% higher than the theoretical level computed based on the company’… https://t.co/Ayhumz0ahn November 18th 2021, 7:11am |
 |
@TradeFlags TD BUY $ANIP at 43.71, Supp 37.38 Resis 56.85 R52 HiLo 52% T1Y 45 buy 2.5 fwdPE 10.6 DIV N/A #ANI Pharma #stocks… https://t.co/Q8XsyPg11D November 18th 2021, 4:11am |
|
@ericpisauro Why does no one care about $anip ? The excitement over cortrophin evaporated so quickly. Isn't there dramatic oppor… https://t.co/4ZFx5mguyg November 17th 2021, 3:11pm |
|
@Tickeron $ANIP enters a Downtrend as Momentum Indicator dropped below the 0 level on November 15, 2021. View odds for this a… https://t.co/xY2xL0Xof8 November 17th 2021, 9:11am |
|
@A1Syad $ANIP Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/2Y60oHpgrx November 17th 2021, 1:11am |
|
@Tickeron $ANIP's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/GBUqs7zpdV November 16th 2021, 12:11pm |
|
@Tickeron $ANIP enters a Downtrend because Momentum Indicator dropped below the 0 level on November 15, 2021. View odds for t… https://t.co/fXtXHO9Kuj November 16th 2021, 7:11am |
|
@A1Syad $ANIP Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/DOG522YSE0 November 15th 2021, 10:11pm |
 |
@aersgrg The CEO’s compensation (6 million) of $ANIP is 90% higher than the theoretical level computed based on the company’… https://t.co/YwBW2MIYgw November 15th 2021, 2:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?